Home » ICH Clinical Trial Guidance Issued for Cancer Drugs
ICH Clinical Trial Guidance Issued for Cancer Drugs
March 17, 2009
An International Conference on Harmonisation (ICH) draft guidance offers recommendations for conducting Phase I clinical trials to assess drug safety and for nonclinical studies of drugs intended for patients with advanced cancer and limited therapeutic options.
To View This Article:
Subscribe To International Pharmaceutical Regulatory Monitor